These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 21619949

  • 1. Therapeutic blockade of TNF in patients with SLE-promising or crazy?
    Aringer M, Smolen JS.
    Autoimmun Rev; 2012 Mar; 11(5):321-5. PubMed ID: 21619949
    [Abstract] [Full Text] [Related]

  • 2. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS.
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of infliximab in active SLE: a pilot study.
    Uppal SS, Hayat SJ, Raghupathy R.
    Lupus; 2009 Jul; 18(8):690-7. PubMed ID: 19502264
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of tumor necrosis factor-alpha in systemic lupus erythematosus.
    Aringer M, Smolen JS.
    Arthritis Res Ther; 2008 Jul; 10(1):202. PubMed ID: 18226185
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
    De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C, Boucquillard E, Siame JL, Mariette X, Club Rhumatismes et Inflammation.
    Arthritis Res Ther; 2005 Jul; 7(3):R545-51. PubMed ID: 15899041
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-TNF-induced lupus.
    Williams EL, Gadola S, Edwards CJ.
    Rheumatology (Oxford); 2009 Jul; 48(7):716-20. PubMed ID: 19416947
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].
    Haake H, Köneke J, Amann K, vom Dahl J, Janssen U.
    Med Klin (Munich); 2007 Oct 15; 102(10):852-7. PubMed ID: 17928969
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Oct 15; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 18. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Rosenau BJ, Schur PH.
    J Rheumatol; 2009 Apr 15; 36(4):753-6. PubMed ID: 19273453
    [Abstract] [Full Text] [Related]

  • 19. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B, Wu J, Chu YW, Wang Y, Wang DP, Wu HS, Xiong SD.
    Rheumatology (Oxford); 2005 Sep 15; 44(9):1108-14. PubMed ID: 15840592
    [Abstract] [Full Text] [Related]

  • 20. Thrombogenicity of TNF alpha in rheumatoid arthritis defined through biological probes: TNF alpha blockers.
    Ferraccioli G, Gremese E.
    Autoimmun Rev; 2004 Jun 15; 3(4):261-6. PubMed ID: 15246021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.